
Hopes were high when the FDA approved the use of Zostavax by Merck in the U.S. The single-dose vaccine licensed for use in healthy Americans age 60 and older seemed to ease the worry of those who would otherwise be devastated by the virus. But despite the hope the vaccine brought, its likelihood of causing several significant side effects, including shingles itself, blindness, and even death,...